Partnership

We know from experience how challenging it is to develop and market innovative pharmaceuticals. There are barriers to entry such as:

• pharmaceutical production costs (including money- and time-consuming clinical trials),
• maintaining qualified R&D teams,
• costs of the R&D infrastructure itself.

This is whywe at Bioceltix are open to cooperation on an “in-licensing” basis, which entails Bioceltix working together with a partner for the purpose of joint development of innovative medicinal technologies. We are looking for projects with commercialisation potential and partners willing to work with us on an “in-licensing” basis.

Why choose us as your partner?

• We are a unique team of specialists with extensive experience in science and business.
• We are investing in a GMP-compliant production facility with a production department capable of pharmaceutical-grade in vitro cell culture. The facility will also include a quality control laboratory fitted with state-of-the-art equipment enabling the full characterisation of the produced cells using validated analytical methods, such as flow cytometry and cytogenetics.
• Commercialisation of research is our speciality. That is why we are ready to take on a portion of the business risk related to the developed project while simultaneously providing support through our scientific competencies and professional facilities.
• We aim to build win-win relations and facilitate free exchange of information with our partners. In fact, we believe that in-licensing is one of the key drivers of development in the current biotechnological landscape.